The Swiss voice in the world since 1935
Top stories
Stay in touch with Switzerland

Swiss offer Geneva space for WHO pathogen exchange 

Tedros in mask
WHO director general Tedros Ghebreyesus thanked Switzerland for offering a secure lab in Geneva. Keystone / Martial Trezzini

Switzerland has offered secure space for the Geneva-based WHO to store pathogen materials as part of a proposed new global mechanism for sharing pathogens in the fight against Covid-19. 

“The pandemic has shown that there is an urgent need for a globally agreed system for sharing pathogen materials and clinical samples, to facilitate the rapid development of medical countermeasures as global public goods,” World Health Organization director-general Tedros Ghebreyesus said on Friday.  

Speaking in closing remarks to a virtual WHO Assembly, he stressed this was needed quickly. 

The WHO is proposing “a new approach that would include a repository for materials housed by WHO in a secure Swiss facility; an agreement that sharing materials into this repository is voluntary; that WHO can facilitate the transfer and use of the materials; and a set of criteria under which WHO would distribute them”.  

Ghebreyesus said a number of countries had shown interest. He thanked Swiss health minister Alain Berset and the federal government “for offering a BSL 4 lab to support this initiative”. 

COVAX on track 

Meanwhile, the COVAX vaccine pool led by WHO and the Gavi Vaccine Alliance said on Friday it has exceeded its interim target of raising more than $2 billion (CHF1.83 billion) to buy and distribute Covid-19 vaccines for poorer countries.  

These funds will allow COVAX to buy an initial one billion vaccine doses for 92 eligible countries that would not otherwise be able to afford them, according to a Gavi statement. But it said a further $5 billion will be needed in 2021 to buy Covid-19 vaccine doses as they come through development and are approved by regulators. 

Gavi chief Seth Berkley also told journalists on Friday that US drugmaker Pfizer and its partner BioNTech, who this week said their Covid-19 vaccine was 90% effective in initial trials, had expressed interest in supplying doses to COVAX. 


Popular Stories

Most Discussed

News

Valais National Councillor Bregy is the new President of Mitte Schweiz

More

Philipp Matthias Bregy named new president of Centre Party

This content was published on Valais National Councillor Philipp Matthias Bregy is the new President of the Centre Party. The delegates elected him as the successor to Gerhard Pfister on Saturday in Bern without discussion.

Read more: Philipp Matthias Bregy named new president of Centre Party
A worldwide call for active neutrality launched from Geneva

More

Global call for active neutrality launched from Geneva

This content was published on A number of players have launched a worldwide appeal for active neutrality in Geneva at a time when the major powers are taking a tougher line. The city is competing with Vienna to attract an international congress on this issue in 2026.

Read more: Global call for active neutrality launched from Geneva
Macron invites President Keller-Sutter

More

Macron invites Swiss president to Paris

This content was published on Swiss Finance Minister Karin Keller-Sutter, who holds the rotating Swiss presidency this year, has been invited to Paris by French President Emmanuel Macron.

Read more: Macron invites Swiss president to Paris

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR